Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $129.16M | $158.91M | 53.64% | +$29.75M |
| Merus N V | 1,600,000 | 1,600,000 | 0 | $37.73M | $44.00M | 14.85% | +$6.27M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 3,760,869 | 3,760,869 | 0 | $39.00M | $34.34M | 11.59% | -$4.66M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $26.54M | $32.05M | 10.82% | +$5.51M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $27.27M | $26.93M | 9.09% | -$334.4K |
| VAXCYTE INCCOM(PCVX) | 1,049,893 | 0 | -1,049,893 | $53.52M | $0 | — | -$53.52M |